Cargando…
Reimagining diversity in multiple myeloma clinical trials
Autores principales: | Habr, Dany, Corsaro, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790672/ https://www.ncbi.nlm.nih.gov/pubmed/35391496 http://dx.doi.org/10.1002/hon.2997 |
Ejemplares similares
-
Age Is Just a Number: Considerations for Older Adults in Cancer Clinical Trials
por: Habr, Dany, et al.
Publicado: (2021) -
Reimagining Global Oncology Clinical Trials for the Postpandemic Era: A Call to Arms
por: Saini, Kamal S., et al.
Publicado: (2020) -
Reimagining and reinvesting in rural hospital markets
por: Carroll, Caitlin, et al.
Publicado: (2022) -
Reimagining peer review as an expert elicitation process
por: Marcoci, Alexandru, et al.
Publicado: (2022) -
Not neutral: reimagining antiracism as a professional competence
por: Sharda, Saroo, et al.
Publicado: (2021)